Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
Dave Marver

Dave Marver

Chief Executive Officer, ONWARD Medical

Appears in 1 story

Notable Quotes

The initiation of Empower BP marks another significant milestone in our journey to restore critical autonomic functions impacted by spinal cord injury.

With today's FDA de novo classification and authorization to market the ARC-EX System in the US, a new era begins for people with chronic spinal cord injury.

Stories

Restoring function after paralysis

New Capabilities

Leading company through commercial launch and pivotal trials

For decades, blood pressure instability has silently debilitated people with spinal cord injuries—78% of those with cervical injuries experience dangerous drops when sitting upright, yet only 28% receive treatment that actually works. ONWARD Medical just enrolled the first participant in a pivotal trial testing whether an implanted spinal cord stimulator can solve this problem by restoring the autonomic signals that paralysis disrupts.

Updated Feb 4